Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 50268-190

2 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50268-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flexeril (cyclobenzaprine HCl) Structural Formula Illustration (8b931a82 Figure 01)

Flexeril (cyclobenzaprine HCl) Structural Formula Illustration (8b931a82 Figure 01)
Chemical structure of Cyclobenzaprine Hydrochloride, showing its molecular framework with aromatic rings and functional groups.*
FDA Label Image

1 (190 15)

1 (190 15)
Cyclobenzaprine Hydrochloride 5 mg film-coated tablets label showing two identical sections with NDC 50268-190-15, each containing 50 tablets (5 x 10) in unit dose packaging. The label includes storage instructions, a QR code, manufacturer information for AvKARE, and the AvPAK logo at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.